Tag: Cancer: Cervical
Algorithm Evaluates Cervical Images to ID Precancer, Cancer
Deep learning-based algorithm was validated using archived, digitized cervical screening images
Cervical Cancer Screening Rates ‘Unacceptably Low’
Just 64.6 percent of 30- to 65-year-old women up to date, but Pap-HPV cotesting has increased
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
HPV-16/18 confers strong future risk, particularly in women younger than 30 years
Age to Stop Cervical Cancer Screening Depends on Test Used
Negative HPV test, HPV-cytology co-test tied to low remaining lifetime cancer risk for unvaccinated
Minimally Invasive Sx May Up Mortality in Early Cervical Cancer
Two studies show increased mortality and reduced disease-free, overall survival versus open surgery
Positive HPV Status Tied to Better Cervical Cancer Prognosis
Five-year relative survival ratio better for hrHPV-positive cases than for hrHPV-negative cases
Catch-Up HPV Doses Effective to Age 21 Against Cervical Neoplasia
But catch-up doses not effective against CIN for women who initiated vaccination at 21 to 26 years
USPSTF Updates Guidance for Cervical Cancer Screening
Cytology recommended every three years from age 21; different screening options from age 30 to 65
HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis
Use of primary HPV testing results in significantly lower odds of CIN3+ compared with cytology testing
Good Evidence That HPV Vaccines Protect Against Cervical Precancer
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
